Use of phosphate-binding agents is associated with a lower risk of mortalityJorge B. Cannata‐Andía, Carmine Zoccali, Willem Jan W. Bos et al.|Kidney International|2013Cited by 158
COSMOS: the dialysis scenario of CKD–MBD in EuropeJosé Luis Fernández Martín, Jorge B. Cannata‐Andía, Juan Jesús Carrero et al.|Nephrology Dialysis Transplantation|2012Cited by 92
Influence of Body Mass Index on the Association of Weight Changes with Mortality in Hemodialysis PatientsIván Cabezas‐Rodríguez, Jorge B. Cannata‐Andía, Juan Jesús Carrero et al.|Clinical Journal of the American Society of Nephrology|2013Cited by 63
Current Management of Secondary Hyperparathyroidism: a Multicenter Observational Study (COSMOS)Jorge B. Cannata‐Andía, Mihael Benedik, Carmine Zoccali et al.|Journal of Nephrology|2008Cited by 34
Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS studyJosé Luis Fernández Martín, S. Croft, Adriana Dusso et al.|Nephrology Dialysis Transplantation|2018Cited by 33